Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Atherosclerosis ; 163(2): 249-59, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12052471

ABSTRACT

Oxidative modification of lipoproteins may trigger and maintain atherogenesis. We compared the effects of different antioxidants (alpha-tocopherol, probucol, ubiquinone-10) at doses similar to those used in humans in Watanabe Heritable Hyperlipidemic (WHHL) rabbits for 12 months. Aortic lesions were analyzed for their extent and cellular composition of lesions, mean thickness of fibrous caps and density of smooth muscle cells therein, content of antioxidants, non-oxidized and oxidized lipids. Compared to controls, probucol significantly lowered the extent and macrophage content of lesions and increased the existence and smooth muscle cell density of fibrous caps. alpha-Tocopherol supplementation increased the aortic content of vitamin E, but had no decreasing effect on either the accumulation of macrophage-specific antigen in the aorta or lesion size. Nevertheless, both probucol and alpha-tocopherol significantly decreased in vitro LDL oxidizability, measured under typically strong oxidative conditions. Ubiquinone-10 supplement increased lesion size and the fraction of lesions containing fibrous caps; however, LDL oxidizability remained unaffected by ubiquinone-10 treatment. None of the antioxidants tested lowered oxidized lipids within aortic tissue; however, long-term treatment with probucol provided the most effective anti-atherosclerotic effect, while alpha-tocopherol may be pro-atherogenic and ubiquinone-10 exerts ambivalent effects. Our data suggest that (i) widely used oxidation measures, such as ex-vivo LDL oxidizability, do not reflect the degree of atherosclerosis; and (ii) long-term beneficial effects of relatively low doses of antioxidants may be outweighed by high levels of plasma cholesterol in WHHL rabbits.


Subject(s)
Antioxidants/administration & dosage , Arteriosclerosis/drug therapy , Probucol/administration & dosage , Ubiquinone/analogs & derivatives , Ubiquinone/administration & dosage , alpha-Tocopherol/administration & dosage , Animals , Antioxidants/pharmacokinetics , Aorta/metabolism , Aorta/pathology , Arteriosclerosis/metabolism , Arteriosclerosis/pathology , Coenzymes , Disease Models, Animal , Female , Humans , Lipids/blood , Lipoproteins, LDL/metabolism , Male , Probucol/pharmacokinetics , Rabbits , Ubiquinone/metabolism , Ubiquinone/pharmacokinetics , Vitamin E/metabolism , alpha-Tocopherol/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...